Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Type III/IV Muscle Afferents in Airway and Thermoregulatory Responses
NCT07452094Phase 1Not yet recruiting
- Sponsor
- Northern Arizona University
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial (2 arms), sponsored by Northern Arizona University. Primary endpoints: Airway resistance at 2 weeks, Sweat rate at 2 weeks and 1 more. Planned start Apr 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07452094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07452094.